4//SEC Filing
Jimenez Freddy A. 4
Accession 0001415889-24-015542
CIK 0000744218other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 4:04 PM ET
Size
8.6 KB
Accession
0001415889-24-015542
Insider Transaction Report
Form 4
Jimenez Freddy A.
SVP & GENERAL COUNSEL
Transactions
- Exercise/Conversion
Incentive Stock Option (Right to Buy)
2024-06-03−8,006→ 27,994 totalExercise: $10.38Exp: 2030-06-18→ Common Stock (8,006 underlying) - Exercise/Conversion
Common Stock
2024-06-03$10.38/sh+8,006$83,102→ 33,930 total - Sale
Common Stock
2024-06-03$33.60/sh−8,006$269,002→ 25,924 total
Footnotes (1)
- [F1]25% vested on June 18, 2021 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.
Documents
Issuer
Celldex Therapeutics, Inc.
CIK 0000744218
Entity typeother
Related Parties
1- filerCIK 0001838114
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 4:04 PM ET
- Size
- 8.6 KB